Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type HypersensitivityBehzad Kharabi Masouleh, Martin Götte|The Journal of Immunology|2009Cited by 59
ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaMatthew S. Davids, Javier Pinilla Ibarz, Ian W. Flinn et al.|Blood|2022Cited by 12